TrialClinical journal of the American Society of Nephrology : CJASN2026

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy.

Hiddo J L Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.